Real-world evidence

Collect comprehensive, longitudinal data with specificity and ease

Verily Viewpoint Evidence enables comprehensive and longitudinal real-world data collection to generate high-quality evidence across the pharmaceutical product lifecycle for more complete, insightful clinical research.

  • Consented participants to easily re-engage for streamlining new studies, deploying surveys, data linkage, and more.
  • Unified medical records with rich clinical data, such as unstructured EHR data, provide longitudinal patient views.
  • Research-ready datasets refined on the Verily platform, enriched with fit-for-purpose variables for precision research.

Build tailored, representative cohorts in key therapeutic areas, either to follow a cohort of your study participants for simplified long-term follow up, or to gain insight into a new cohort of participants that Verily engages.

Explore a partnership

Relevant, representative cohorts

Build representative cohorts.
Derive more relevant insights.

Build representative cohorts via tools that assemble via multiple pathways. Choose from these three options:

  1. Onboarding your own participants for long-term follow-up, carrying forward valuable clinical trial data — like investigational arm assignment and endpoint data — to create a robust, longitudinal dataset.
  2. Drawing from Verily’s existing, engaged participant base.
  3. Recruiting new populations with targeted outreach.
Collage of people representing diverse clinical study cohorts, along with examples of various inclusion and exclusion criteria.

Highly-engaged research participants

Woman in her thirties who is part of Verily’s consented community on cardiometabolic condition research, working out at a gym.

A captivated, consented community

Reveal more insights — Less time, less friction

Utilize tools to access Verily’s community of engaged, consented participants who can be re-contacted for new research.

This enables moving beyond retrospective analysis, to generating new, prospective data to answer emerging questions. Tactics:

  • Deploy custom surveys and ePROs
  • Clarify existing data points
  • Offer participants follow-up molecular testing

With Verily Viewpoint Evidence, we’re able to rapidly build cohorts of consented participants who can be reengaged. The result is high-quality datasets that unlock meaningful insights for retrospective and prospective studies.

Dr. Andrew Trister, MD, PhD
Verily Chief Medical and Scientific Officer

Sharper views of health journeys

Collage of a woman viewing her medicine and examples of health data sources, such as medical claims.

Connected, clinically-rich records

Gain a detailed, longitudinal participant perspective

Viewpoint Evidence builds a multimodal view of health journeys, unifying holistic health records from consented participants’ health systems, pharmacies, and personal devices. Overcoming data fragmentation, this creates a longitudinal record with robust clinical data, e.g., labs, vitals, and unstructured notes.

Curated on the Verily platform, this rich clinical asset also serves as a base to link with other data types, e.g., claims, genomics, or patient-reported outcomes (PROs) from Verily-engaged groups.

Curated, research-ready datasets

The Verily platform and AI

Transform data from messy and raw to clean & enriched

Viewpoint Evidence provides datasets rigorously refined on the Verily platform, which harmonizes inconsistent codes and terminology from disparate sources, and leverages AI to extract critical insights from unstructured EHR data, e.g., physician notes and pathology reports.

The output — clean, research-ready datasets, enriched with bespoke variables for answering your specific questions.

Simulation of Verily’s platform harmonizing disparate, multimodal clinical datasets.